Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
HUTCHISON CH MEDIT
(SEA:
HCM
)
4.950
GBP
UNCHANGED
Streaming Delayed Price
/ Updated:
11:17 AM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
8,624
Open
4.950
Bid (Size)
4.982 (0)
Ask (Size)
4.987 (0)
Prev. Close
4.950
Today's Range
4.950 - 4.982
52wk Range
3.400 - 5.995
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
The Week in Review: Sagent Buys Out China JV Partner for $25 Million
May 11, 2013
Sagent Pharma, a US generic injectible drugmaker, will pay $25 million to acquire its partner’s 50% interest in a China manufacturing JV; ScinoPharm Taiwan and Coland Holdings formed a partnership to...
Read More
from
ChinaBio® Today
Execupay Integrates with HR 360 to Offer an Online HR Department
May 09, 2013
category
hcm
,
San Antonio
,
Technology
, and 5 more.
from
PRLog
More News
Read More
Hutchison Chi-Med in Partner Talks for Cancer Drug
May 09, 2013
from
ChinaBio® Today
Li Ka-Shing Donates $31 Million to Medical Research Institute at Oxford
May 03, 2013
from
ChinaBio® Today
Week in Review: Hutchison Chi-Med Forms Drug Development JV with Nestlé
December 01, 2012
from
ChinaBio® Today
Chi-Med and Nestlé Form JV to Develop Chi-Med’s Lead Drug Candidate
November 28, 2012
from
ChinaBio® Today
Week in Review: Charles River Labs Buys China’s Vital River
November 03, 2012
from
ChinaBio® Today
Hutchison MediPharma Starts Clinical Trial on Fourth Cancer Drug
November 02, 2012
from
ChinaBio® Today
Hutchison MediPharma Starts Phase I Trial of Fourth Cancer Molecule
February 22, 2012
from
ChinaBio® Today
UPDATE 1-AstraZeneca places two new bets after R&D setbacks
December 21, 2011
category
companyNews
from
Reuters: Company News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here